Patients with SLE and SLD had a lower frequency of hydroxychloroquine use (65% vs 84%, p = 0.04), and higher C3 levels [123mg/dl (IQR 102–136) vs 99mg/dl (IQR 78–121), p = 0.004]. Here, C3 is linked to systemic lupus erythematosus.